Vir Biotechnology, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
Vir Biotechnology, Inc. is a biotechnology research company focused on harnessing the immune system to develop medicines for serious infectious diseases and cancer. Its work emphasizes areas where it believes it can most benefit patients, with foundational efforts in chronic hepatitis delta complemented by oncology programs. The company's two technology platforms enable rapid identification and advancement of candidates from concept to clinical testing: a next-generation antibody platform and a protease-releasable masking platform, applicable in infectious disease and cancer. It is headquartered in San Francisco, California, and employs between 201 and 500 people. Vir has pursued strategic collaborations, including a global agreement with Astellas Pharma to co-develop a prostate cancer immunotherapy, which ended in April 2026.